Sonocine

About Sonocine

SonoCiné is a medical technology company specializing in advanced breast cancer screening solutions. The company operates in the healthcare sector, focusing on providing automated whole breast ultrasound (AWBUS) technology. This technology is designed to detect breast cancers that traditional mammography might miss, particularly in women with dense breast tissue. SonoCiné serves healthcare providers, including hospitals, clinics, and specialized breast imaging centers. The company's business model revolves around selling and leasing its AWBUS equipment to these medical institutions, as well as providing ongoing support and training. Revenue is generated through equipment sales, leasing agreements, and service contracts.

SonoCiné's market includes regions with high breast cancer screening rates and a focus on early detection, primarily in North America and Europe. The company's technology has been adopted by early adopters in the medical community, and it has demonstrated success in detecting additional invasive ductal cancers that were not visible through mammography alone. This positions SonoCiné as a critical player in the breast cancer screening market, offering a complementary tool to existing mammography practices.